Biosense Webster Patents – Insights & Stats (Updated 2024)

Biosense Webster has a total of 2874 patents globally, out of which 2088 have been granted. Of these 2874 patents, more than 33% patents are active. United States of America is where Biosense Webster has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Biosense Webster.

Biosense Webster was founded in the year 1970. The Company manufactures electromedical and electrotherapeutic apparatus. The Company offers therapeutic and ultrasound catheters, generators, cables and accessories.

Do read about some of the most popular patents of Biosense Webster which have been covered by us in this article and also you can find Biosense Webster patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Biosense Webster patent portfolio.

How many patents does Biosense Webster have?

Biosense Webster has a total of 2874 patents globally. These patents belong to 393 unique patent families. Out of 2874 patents, 968 patents are active.

How Many Patents did Biosense Webster File Every Year?

Biosense Webster Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBiosense Webster Applications FiledBiosense Webster Patents Granted
20243
202313
20221214
202129
20201029
20191653
20181160
20172298
20168131
201521165
20148140
201317205

How many Biosense Webster patents are Alive/Dead?

Biosense Webster Patent Portfolio

 How Many Patents did Biosense Webster File in Different Countries?

Biosense Webster Worldwide Patent Filing

Countries in which Biosense Webster Filed Patents

CountryPatents
United States of America400
Europe (EPO)397
Germany308
Japan305
Israel226
Austria222
Canada181
Australia176
China131
Korea (South)86
India85
Hong Kong (S.A.R.)67
Denmark52
Spain43
Mexico28
Portugal25
Russian Federation23
Brazil20
Italy16
Slovenia12
Slovakia8
United Kingdom8
Estonia6
Poland6
Cyprus4
Malta2

Where are Research Centres of Biosense Webster Patents Located?

R&D Centers of Biosense Webster

10 Best Biosense Webster Patents

US7397364B2 is the most popular patent in the Biosense Webster portfolio. It has received 1476 citations so far from companies like Mija Industries, Inc., General Electric and Covidien Lp.

Below is the list of 10 most cited patents of Biosense Webster:

Publication NumberCitation Count
US7397364B21476
US6995729B21369
US8214019B21257
US7842025B21218
US7536218B21011
US7756576B2686
US8456182B2582
US6602242B1539
US6564096B2524
US8287532B2433

How many inventions of other companies were rejected due to Biosense Webster patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Biosense Webster invention. They couldn’t because Biosense Webster had protected those before them.

Examiners at the USPTO referred 225 Biosense Webster patents in 1685 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Biosense Webster patent portfolio are St Jude Medical Atrial Fibrillation Division, Boston Scientific Scimed and St Jude Medical Cardiology Division.

List of the Companies whose Patents were rejected citing Biosense Webster –

CompanyNumber of Patent Applications that faced Rejection Citing Biosense Webster PatentsNumber of Rejections (102 & 103)
St Jude Medical Atrial Fibrillation Division61188
Boston Scientific Scimed56114
St Jude Medical Cardiology Division3279
Medtronic31123
Covidien2867
Koninklijke Philips2284
Auris Health1332
Olympus Corporation916
General Electric927
St Jude Medical International Holding Sà Rl819

Count of 102 and 103 Type Rejections based on Biosense Webster Patents

Top Biosense Webster Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US7306593B230
US7996060B215
US7655005B213
US7536218B213
US6551274B212
US20060241445A112
US8728073B212
US9629567B212
US8046049B211
US7604601B211
US6564096B210
US7918851B210
US7918793B29
US7591799B29
US7855723B29

What Percentage of Biosense Webster US Patent Applications were Granted?

Biosense Webster (Excluding its subsidiaries) has filed 157 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 134 have been granted leading to a grant rate of 87.58%.

Below are the key stats of Biosense Webster patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Biosense Webster?

Law FirmTotal ApplicationsSuccess Rate
Lewis Roca Rothgerber Christie Llp8696.51%
Calderon Safran & Cole Pc850.00%
Christie Parker & Hale Llp5100.00%
Seyfarth Shaw Llp475.00%
Lawrence Livermore National Security Llc10.00%
Nawrocki Rooney & Sivertson1100.00%
Scully Scott Murphy & Presser Pc1100.00%

What are Biosense Webster key innovation segments?

What Technologies are Covered by Biosense Webster?

The chart below distributes patents filed by Biosense Webster in different countries on the basis of the technology protected in patents. It also represents the markets where Biosense Webster thinks it’s important to protect particular technology inventions.

R&D Focus: How has Biosense Webster search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Biosense Webster?

Related Articles

Treetoscope Patents – Insights & Stats (Updated 2024)

Treetoscope has a total of 7 patents globally, out of which no patents have been granted. Of these 7 patents, more than 85% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Treetoscope. Treetoscope was

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.